Engineered transgenes can be introduced into T cells to generate effector and memory CD8 and CD4 T lymphocytes specific for viral, fungal, bacterial, parasitic, and tumor-antigens and to design regulatory lymphocytes specific for the self-antigens responsible for autoimmune and inflammatory diseases (4). Here, CD4 is linked to neoplasm.